Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia
Fanny Vaillant(Montreal Heart Institute), Christine Des Rosiers(Montreal Heart Institute)
American Journal of Physiology-Heart and Circulatory Physiology
August 6, 2016
Cited by 12
Related Papers
Assessing Cardiac Metabolism
|Circulation Research|2016|284
Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn’s Disease
|Inflammatory Bowel Diseases|2023|29
Serum Analyte Profiles Associated With Crohn’s Disease and Disease Location
|Inflammatory Bowel Diseases|2021|27
Remodeling of lipid landscape in high fat fed very-long chain acyl-CoA dehydrogenase null mice favors pro-arrhythmic polyunsaturated fatty acids and their downstream metabolites
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2023|9